M.D. Anderson Cancer Center [clinicaltrials_resource:6f414a642fffdb8268f5874fbb382ccc]
Christopher Lieu [clinicaltrials_resource:003e0aec3cb8c2eec216114deb9adc28]William G. Wierda, M.D., PhD [clinicaltrials_resource:005cb837e868167ac42317d6942c4af8]Jason R. Westin, MD [clinicaltrials_resource:0084f7a9cf91ec9b54aa9119a6765c26]Hagop Kantarjian, M.D. [clinicaltrials_resource:009d38a93bbe1c0d6eb327869719cc12]Issa F. Khouri, MD [clinicaltrials_resource:010b8c2d9f5e56d4ccd4b1a4889598d4]Charlotte C. Sun, MD [clinicaltrials_resource:0167532e6853feae95ef3af24a7958b1]Richard A. Hajek, PHD, MS, BA [clinicaltrials_resource:0187ec0c67e652275a23e7b0f380c0ee]Dan Gombos, MD [clinicaltrials_resource:01ce1a85abb160bef087a3279dea4aeb]Quynh-nhu Nguyen, MD [clinicaltrials_resource:02021bfe842137df765baa794ad172b1]Peter W. T. Pisters, MD [clinicaltrials_resource:02418dd16c2e9b09d03719fe3caee5de]Joe Y. Chang, MD, PhD [clinicaltrials_resource:02708c28f7f6fa7b7602a4798ba9d209]Amy Heimberger, MD [clinicaltrials_resource:027525a7d139b0a75c7206872f729d40]Elizabeth A Mittendorf, MD,FACS [clinicaltrials_resource:02ab1422e9ad2687c32193290080fb76]Edmund Kopetz [clinicaltrials_resource:02b707cf9c39414d3887a4a9a7904fcc]Tapan Kadia, MD [clinicaltrials_resource:02ba5453849cf44ebc85a9089d3b8362]Dave Balachandran, MD [clinicaltrials_resource:02ed276d3979c893687fdc853527383d]Christopher Logothetis, MD [clinicaltrials_resource:0303f1821dfe7bcc2951aa1e0cbb1e37]John Heymach, MD, PHD [clinicaltrials_resource:0333ebb2d01ab6c84a9c83a68df85506]Yehuda Z. Patt, MD [clinicaltrials_resource:03ec8cd127c5f970025a0938778d605b]Patricia A. Parker, PhD [clinicaltrials_resource:0412b713c79484ef3d6cd433433d4bdd]Benjamin Lichtiger, MD [clinicaltrials_resource:046c98aac69fc91fb6d8ff7a72eecd28]Antonio Pellicer, MDPhD [clinicaltrials_resource:04d4442faff5f7e35e194ccdd801cc11]Guillermo Garcia-Manero, MD [clinicaltrials_resource:04e6532b26a59037389b01bae2859171]Valerae O. Lewis, MD [clinicaltrials_resource:04e7e4abce08f426bd2c18b908f70758]George Chang, MD, MS [clinicaltrials_resource:0523875963ffe25ea448bc09f0ba8dcb]Eugene J. Koay, MD,PHD [clinicaltrials_resource:057d90f59e4ea51c35bf3f1095229538]Jatin J. Shah, MD [clinicaltrials_resource:0588bece403c9b37bef1cc7186f0b925]Abenaa M. Brewster, MD, MHS, BS [clinicaltrials_resource:05de1947d8ac3fb6bb2fdfd1c8e37a4b]Michael M. Frumovitz, MD [clinicaltrials_resource:063f17cf96810e37d141898106e4b9d7]Joseph S. Chiang, MD [clinicaltrials_resource:0645d980f3a5d86f755554079c67d709]Christopher G. Wood, MD [clinicaltrials_resource:06538b1b3b2e833f92d7a440bc6ddcea]Ahmed Kaseb, M.D. [clinicaltrials_resource:068ba02bae42b5088caf4a8305765557]Sai-Ching J. Yeung, MD, PHD [clinicaltrials_resource:07186d2a6c21db10a751cb02a1825ad5]Partow Kebriaei, MD [clinicaltrials_resource:0761cc8d0cdab0229c86ebbbf20c4dc4]Robert Volk, PhD [clinicaltrials_resource:077f8a42210dc4538947142577740bb9]Lorna H McNeill, PHD, MPH [clinicaltrials_resource:07a6734c6c62978ec0530bb3658eebe8]Christopher P. Fagundes, PHD [clinicaltrials_resource:07aeb36de3f1671c751507db1c86f2d2]John deGroot, MD [clinicaltrials_resource:0818f0fb7eb8212fea240d8fefc8f285]Mehnaz A. Shafi, MD [clinicaltrials_resource:08274e4598e331e9b3d31520ee53263b]Aung Naing [clinicaltrials_resource:0871713cb7496233e1097d53719daebe]
affiliation [clinicaltrials_vocabulary:affiliation]
clinicaltrials:NCT00002463clinicaltrials:NCT00002524Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma [clinicaltrials:NCT00002565]clinicaltrials:NCT00002682clinicaltrials:NCT00002829clinicaltrials:NCT00002831clinicaltrials:NCT00002832clinicaltrials:NCT00002833clinicaltrials:NCT00002835clinicaltrials:NCT00002836clinicaltrials:NCT00002837clinicaltrials:NCT00002838clinicaltrials:NCT00002844clinicaltrials:NCT00002855clinicaltrials:NCT00002882clinicaltrials:NCT00002965clinicaltrials:NCT00003046clinicaltrials:NCT00003048Fenretinide in Treating Patients With Cervical Neoplasia [clinicaltrials:NCT00003075]clinicaltrials:NCT00003084clinicaltrials:NCT00003099clinicaltrials:NCT00003239Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003245]Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma [clinicaltrials:NCT00003311]clinicaltrials:NCT00003441Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas [clinicaltrials:NCT00003564]Vitamin E in Preventing the Side Effects of Isotretinoin in Former and Current Smokers Who Are Receiving Isotretinoin to Prevent Lung Cancer [clinicaltrials:NCT00003599]clinicaltrials:NCT00003645clinicaltrials:NCT00003677clinicaltrials:NCT00003693Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer [clinicaltrials:NCT00003714]clinicaltrials:NCT00004109clinicaltrials:NCT00004123Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer [clinicaltrials:NCT00004136]clinicaltrials:NCT00004142Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer [clinicaltrials:NCT00004154]clinicaltrials:NCT00004246clinicaltrials:NCT00004263SCH 66336 Before Surgery in Treating Patients With Colorectal Cancer That Has Metastasized to the Liver [clinicaltrials:NCT00005030]clinicaltrials:NCT00005092
collaborator [clinicaltrials_vocabulary:collaborator]
clinicaltrials:NCT00002463clinicaltrials:NCT00002524Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma [clinicaltrials:NCT00002565]clinicaltrials:NCT00002682clinicaltrials:NCT00002829clinicaltrials:NCT00002831clinicaltrials:NCT00002832clinicaltrials:NCT00002833clinicaltrials:NCT00002835clinicaltrials:NCT00002836clinicaltrials:NCT00002837clinicaltrials:NCT00002838clinicaltrials:NCT00002844clinicaltrials:NCT00002855clinicaltrials:NCT00002882clinicaltrials:NCT00002965clinicaltrials:NCT00003046clinicaltrials:NCT00003048Fenretinide in Treating Patients With Cervical Neoplasia [clinicaltrials:NCT00003075]clinicaltrials:NCT00003084clinicaltrials:NCT00003099clinicaltrials:NCT00003239Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003245]Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma [clinicaltrials:NCT00003311]clinicaltrials:NCT00003441Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas [clinicaltrials:NCT00003564]Vitamin E in Preventing the Side Effects of Isotretinoin in Former and Current Smokers Who Are Receiving Isotretinoin to Prevent Lung Cancer [clinicaltrials:NCT00003599]clinicaltrials:NCT00003645clinicaltrials:NCT00003677clinicaltrials:NCT00003693Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer [clinicaltrials:NCT00003714]clinicaltrials:NCT00004109clinicaltrials:NCT00004123Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer [clinicaltrials:NCT00004136]clinicaltrials:NCT00004142Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer [clinicaltrials:NCT00004154]clinicaltrials:NCT00004246clinicaltrials:NCT00004263SCH 66336 Before Surgery in Treating Patients With Colorectal Cancer That Has Metastasized to the Liver [clinicaltrials:NCT00005030]clinicaltrials:NCT00005092
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
clinicaltrials:NCT00002463clinicaltrials:NCT00002524Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma [clinicaltrials:NCT00002565]clinicaltrials:NCT00002682clinicaltrials:NCT00002829clinicaltrials:NCT00002831clinicaltrials:NCT00002832clinicaltrials:NCT00002833clinicaltrials:NCT00002835clinicaltrials:NCT00002836clinicaltrials:NCT00002837clinicaltrials:NCT00002838clinicaltrials:NCT00002844clinicaltrials:NCT00002855clinicaltrials:NCT00002882clinicaltrials:NCT00002965clinicaltrials:NCT00003046clinicaltrials:NCT00003048Fenretinide in Treating Patients With Cervical Neoplasia [clinicaltrials:NCT00003075]clinicaltrials:NCT00003084clinicaltrials:NCT00003099clinicaltrials:NCT00003239Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003245]Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma [clinicaltrials:NCT00003311]clinicaltrials:NCT00003441Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas [clinicaltrials:NCT00003564]Vitamin E in Preventing the Side Effects of Isotretinoin in Former and Current Smokers Who Are Receiving Isotretinoin to Prevent Lung Cancer [clinicaltrials:NCT00003599]clinicaltrials:NCT00003645clinicaltrials:NCT00003677clinicaltrials:NCT00003693Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer [clinicaltrials:NCT00003714]clinicaltrials:NCT00004109clinicaltrials:NCT00004123Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer [clinicaltrials:NCT00004136]clinicaltrials:NCT00004142Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer [clinicaltrials:NCT00004154]clinicaltrials:NCT00004246clinicaltrials:NCT00004263SCH 66336 Before Surgery in Treating Patients With Colorectal Cancer That Has Metastasized to the Liver [clinicaltrials:NCT00005030]clinicaltrials:NCT00005092
source [clinicaltrials_vocabulary:source]
M.D. Anderson Cancer Center [clinicaltrials_resource:6f414a642fffdb8268f5874fbb382ccc]
Bio2RDF identifier
6f414a642fffdb8268f5874fbb382ccc
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:6f414a642fffdb8268f5874fbb382ccc
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:6f414a642fffdb8268f5874fbb382ccc
title
M.D. Anderson Cancer Center
@en
type
label
M.D. Anderson Cancer Center [clinicaltrials_resource:6f414a642fffdb8268f5874fbb382ccc]
@en